Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality

Understanding the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on solid tumor risk and mortality can shed light on novel cancer pathways.